Vaccine adjuvants: A priority for vaccine research
| Autor: | Harandi AM, Medaglini D, Shattock RJ, Working Group convened by EUROPRISE, Polyanskaya N, Agger EM, Bianchi M, Carter D, Debre P, Didierlaurent A, Gancberg D, De Gregorio E, Haensler J, Kelly C, Klavinskis L, Lehner T, Lindblad EB, Lonnroth A, De Magistris MT, Martini A, Modabber F, van der Most R, Nagy E, Romaris M, Sesardic D, Vendetti S, Verrier B, Wagner H, Wegmann F., POLI , GUIDO |
|---|---|
| Přispěvatelé: | Harandi, Am, Medaglini, D, Shattock, Rj, Working Group convened by, Europrise, Polyanskaya, N, Agger, Em, Bianchi, M, Carter, D, Debre, P, Didierlaurent, A, Gancberg, D, De Gregorio, E, Haensler, J, Kelly, C, Klavinskis, L, Lehner, T, Lindblad, Eb, Lonnroth, A, De Magistris, Mt, Martini, A, Modabber, F, van der Most, R, Nagy, E, Poli, Guido, Romaris, M, Sesardic, D, Vendetti, S, Verrier, B, Wagner, H, Wegmann, F. |
| Rok vydání: | 2010 |
| Předmět: |
Vaccine research
medicine.medical_specialty Tuberculosis General Veterinary General Immunology and Microbiology Poverty business.industry medicine.medical_treatment Public Health Environmental and Occupational Health Immunopotentiator medicine.disease Infectious Diseases Vaccine adjuvant Acquired immunodeficiency syndrome (AIDS) Family medicine Immunology Molecular Medicine Medicine business Adjuvant Malaria |
| Popis: | The workshop on vaccine adjuvants was held in July of 2009 at the European Commission in Brussels, with the goal of identifying key scientific priorities as they pertain to the development of effective vaccines against life-threatening diseases especially those associated with poverty, including HIV/AIDS, malaria and tuberculosis as well as neglected infectious diseases. On the basis of new advances in adjuvant research and related technology as well as potential challenges and roadblocks, six priorities were identified to accelerate development of improved or novel vaccine adjuvants for human use. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|